Under Trump, FDA seeks to abandon expert reviews of new drugs

Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn't make sense, former officials said.

Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas United States Wyoming US Virgin Islands Utah Vermont Virginia Washington D.C. Washington West Virginia Porters Sideling Pennsylvania Folsom Louisiana
September 12, 2025 at 04:00AM